ANIP — ANI Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.67bn
- $1.90bn
- $883.37m
ANI Pharma rises as rare-disease drugs drive quarterly results beat
U.S. RESEARCH ROUNDUP- Akamai Technologies, Bill Holdings, Veeva Systems
ANI Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: ANI Pharmaceuticals Q3 Adjusted EPS USD 1.34 Vs. IBES Estimate USD 1.09
U.S. RESEARCH ROUNDUP- ANI Pharmaceuticals, Deere & Co, Zoetis
Brief: ANI Pharmaceuticals Announces The FDA Approval And Launch Of Ketoconazole Shampoo
U.S. STOCKS ON THE MOVE- Teladoc Health, Veritex, New York Community Bancorp
U.S. STOCKS ON THE MOVE- AppLovin, Regal Rexnord, Talkspace
Guggenheim raises PT on ANI Pharma after Alimera deal completion
U.S. STOCKS ON THE MOVE-GE Vernova, Dell, Super Micro Computer
U.S. STOCKS ON THE MOVE-Intel, ANI Pharmaceuticals, New York Community Bancorp
Guggenheim raises PT on ANI Pharma after Alimera deal completion
Brief: Ani Pharmaceuticals Initiates Closing Of Acquisition Of Alimera Sciences
Brief: ANI Pharmaceuticals Launches Promethazine Hydrochloride And Dextromethorphan Hydrobromide Oral Solution
Brief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
Alimera Sciences down on filing lawsuit against ANI Pharma to close deal
Brief: ANI Pharmaceuticals Closes $316.25 Mln Convertible Senior Notes Offering
Brief: ANI Pharmaceuticals Prices Upsized $275.0 Million Convertible Senior Notes Offering